What the test actually measures

The six-minute walk distance is a measure of functional capacity — the integrated performance of your heart, lungs, circulation, muscles and joints doing something close to ordinary life. That is its strength. A treadmill test isolates cardiovascular capacity under maximal load; this asks what you can do walking down a corridor, which is a better proxy for whether you can manage the shops.

It has become the standard functional outcome in chronic obstructive pulmonary disease, heart failure, pulmonary hypertension, interstitial lung disease, pulmonary and cardiac rehabilitation, and in the assessment of frailty in older adults. It is also used before and after interventions — lung volume reduction, transplant assessment, exercise programmes — precisely because it responds to change.

How predicted distance is calculated

This calculator uses the Enright and Sherrill reference equations, published in 1998 from 117 healthy men and 173 healthy women aged 40 to 80. Median distances were 576 m for men and 494 m for women.

Men: 6MWD = (7.57 × height cm) − (5.02 × age) − (1.76 × weight kg) − 309
Women: 6MWD = (2.11 × height cm) − (2.29 × weight kg) − (5.78 × age) + 667

Distance falls with age and with weight in both sexes, and rises with height in men. The equations account for roughly 40% of the variation between individuals — which is a genuine limitation, and the reason the result here is presented as a rough band rather than a precise verdict.

The paper also gives a lower limit of normal: 153 m below predicted for men, 139 m below for women. Falling under that line is the more meaningful signal, and the calculator reports it.

Interpreting the number

There is no single threshold that separates health from disease, but some anchors are widely used:

  • Below 300 m is associated with worse outcomes across several conditions, and in heart failure and COPD cohorts has repeatedly predicted higher mortality.
  • Below 350 m in COPD has been linked to increased risk of hospitalisation and death.
  • Above 400 to 450 m generally indicates preserved functional capacity in older adults.
  • Percent predicted below 80% is commonly treated as reduced, though it should always be read alongside symptoms and the lower limit of normal.

These are population associations, not individual predictions. A single distance says far less than the same person's distance measured twice.

Why repeating it matters more than the first result

The most useful thing about this test is its sensitivity to change. The minimal clinically important difference — the smallest change a patient actually notices — is around 30 metres in chronic respiratory disease, with estimates in the literature ranging from about 25 to 33 m. In heart failure it is broadly similar.

So a patient who walks 340 m before pulmonary rehabilitation and 380 m afterwards has made a change that matters to them, regardless of what percent predicted says. That is why respiratory and cardiac rehab programmes measure it at entry and exit.

Two practical notes. There is a well-documented learning effect: the second test is typically 15 to 30 m further than the first, purely from familiarity, which is why guidelines suggest a practice walk when precision matters. And repeat tests should use the same corridor, the same time of day, and the same encouragement, or the comparison is meaningless.

What to do with a low result

A short distance is information, not a sentence. Both cardiac and pulmonary rehabilitation reliably improve six-minute walk distance, often by well above the clinically important threshold, and both are among the better-evidenced interventions in medicine for quality of life.

If your distance is well below predicted, or below the lower limit of normal, or if you desaturated during the walk, that is worth showing to your doctor — those are exactly the findings that prompt useful investigation. If you already have a diagnosed heart or lung condition, ask whether a rehabilitation programme is available to you; many people who would benefit are never referred.

References

  1. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1384–1387. doi:10.1164/ajrccm.158.5.9710086 The reference equations and lower limits of normal used by this calculator.
  2. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117. doi:10.1164/ajrccm.166.1.at1102 The standardised protocol, safety criteria and stopping rules described above.
  3. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society / American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446. doi:10.1183/09031936.00150314 Current technical standard, including the learning effect and the case for a practice walk.
  4. Puhan MA, Chandra D, Mosenifar Z, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011;37(4):784–790. doi:10.1183/09031936.00063810 Source of the roughly 30-metre minimal clinically important difference.
  5. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA. 1993;270(14):1702–1707. doi:10.1001/jama.1993.03510140062030 The SOLVD analysis linking shorter walk distance to mortality in left ventricular dysfunction.